Literature DB >> 6286488

Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.

V C Carter, P L Rice, S S Tevethia.   

Abstract

Cytotoxic T lymphocytes (CTL) were generated in C57BL/6 mice with herpes simplex virus type 1 (HSV-1) (strains KOS, 17, HFEM, and mP) and HSV-2 (strains 186, G, and GP6). Effector lymphocytes were tested for cytotoxicity against syngeneic HSV-1- and HSV-2-infected cells in a 5-h 51Cr release assay. HSV-1 strain HFEM was found to induce CTL efficiently only when 100-fold more virus was used as compared with HSV-1 strains KOS, 17, and mP. All HSV-1 and HSV-2 strains induced cross-reactive populations of CTL. CTL generated by HSV-1 KOS and HSV-2 186 also demonstrated cross-reactivity in an ear-swelling model for delayed-type hypersensitivity. Lymphocytes generated by all HSV-2 strains were highly efficient at lysing HSV-1-infected target cells. However, HSV-2-infected target cells were found to be less susceptible to lysis by either HSV-1 or HSV-2 CTL than were HSV-1-infected target cells. The lowered susceptibility of HSV-2-infected cells was not due to an inefficient infection of BL/6 WT-3 cells as measured by standard growth assays and infectious center assays. Varying the multiplicity of infection or the time of infection did not increase the susceptibility of HSV-2-infected target cells to lysis by CTL. Increasing the effector-to-target-cell ratio resulted in an increased lysis of both HSV-1- and HSV-2-infected target cells by CTL, but the level of HSV-2-infected target cell lysis still did not approach the level of HSV-1-infected target cell lysis. HSV-2-infected cells were as efficient as HSV-1-infected cells in the cold cell competition assay employed in reducing the lysis of 51Cr-labeled, HSV-1-infected target cells. In addition, HSV-2-infected cells were susceptible to lysis by HSV-immune serum and complement.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286488      PMCID: PMC347498          DOI: 10.1128/iai.37.1.116-126.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  J Esparza; D J Purifoy; P A Schaffer; M Benyesh-Melnick
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

2.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

Review 3.  A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.

Authors:  G Plummer
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

4.  Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map.

Authors:  S M Brown; D A Ritchie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

5.  Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2.

Authors:  J W Smith; E Adam; J L Melnick; W E Rawls
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

6.  Sensitization of guinea pigs to herpes simplex virus.

Authors:  H W Rogers; L V Scott; R A Patnode
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

8.  Delayed hypersensitivity to herpes simplex virus in the guinea pig.

Authors:  R N Lausch; J S Swyers; H E Kaufman
Journal:  J Immunol       Date:  1966-06       Impact factor: 5.422

9.  A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties.

Authors:  W E Rawls; D Laurel; J L Melnick; J M Glicksman; R H Kaufman
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

10.  Genetic relatedness of type 1 and type 2 herpes simplex viruses.

Authors:  E Kieff; B Hoyer; S Bachenheimer; B Roizman
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

View more
  8 in total

Review 1.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

2.  Immune response to bovine herpes herpesvirus type 1 infections: virus-specific antibodies in sera from infected animals.

Authors:  J K Collins; A C Butcher; C A Riegel
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

3.  Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.

Authors:  K L Rosenthal; J R Smiley; S South; D C Johnson
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes.

Authors:  V C Carter; S R Jennings; P L Rice; S S Tevethia
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins.

Authors:  S Martin; R J Courtney; G Fowler; B T Rouse
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells.

Authors:  S R Jennings; P L Rice; E D Kloszewski; R W Anderson; D L Thompson; S S Tevethia
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.

Authors:  M A Tigges; D Koelle; K Hartog; R E Sekulovich; L Corey; R L Burke
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2.

Authors:  G H Cohen; D Long; J T Matthews; M May; R Eisenberg
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.